LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy

被引:12
|
作者
Egranov, Sergey D. [1 ]
Hu, Qingsong [1 ]
Lin, Chunru [1 ,2 ]
Yang, Liuqing [1 ,2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Long noncoding RNA; antigen presentation; tumour intrinsic factor; Cancer immunology; LONG NONCODING RNA;
D O I
10.1080/15476286.2020.1767455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long noncoding RNAs (lncRNAs) have been found to associate with all major types of malignancies and play important roles in regulating several hallmarks of cancer by interacting with proteins, DNA, and RNA. The possible functions of lncRNAs and their roles in the regulation of tumour growth will be reported and discussed in the present review. In our recent report, based on genetic mice models and a series of systematic analyses, we suggested that lncRNAs also play critical roles in the regulation of antigen presentation in tumour cells and allow tumour cells to escape immune surveillance, which further broadens the scope of understanding lncRNA functions and how they relate to cancer immunotherapy resistance.
引用
收藏
页码:1625 / 1627
页数:3
相关论文
共 50 条
  • [21] Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer
    Denise Lau
    Sonal Khare
    Michelle M. Stein
    Prerna Jain
    Yinjie Gao
    Aicha BenTaieb
    Tim A. Rand
    Ameen A. Salahudeen
    Aly A. Khan
    Nature Communications, 13
  • [22] Role of Tumor Cell Intrinsic and Host Autophagy in Cancer
    Guo, Jessie Yanxiang
    White, Eileen
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2024, 14 (07):
  • [23] Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer
    Chen, Xiaoxu
    Qin, Zheng
    Zhu, Xiao
    Wang, Lili
    Li, Changying
    Wang, Haitao
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer
    Xiaoxu Chen
    Zheng Qin
    Xiao Zhu
    Lili Wang
    Changying Li
    Haitao Wang
    Scientific Reports, 13
  • [25] Genetic analysis of single tumor cell in cancer immunotherapy
    Ishiguro, Tomoyuki
    Takayanagi, Daisuke
    Takeda, Kazuyoshi
    Tsurui, Toshiaki
    Suzuki, Risako
    Iriguchi, Nana
    Hirasawa, Yuya
    Ohkuma, Ryotaro
    Ariizumi, Hirotsugu
    Hamada, Kazuki
    Horiike, Atsushi
    Wada, Satoshi
    Yoshimura, Kiyoshi
    Tsunoda, Takuya
    CANCER SCIENCE, 2023, 114 : 346 - 346
  • [26] Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy
    Mia C. Borlongan
    Dipongkor Saha
    Hongbin Wang
    Stem Cell Reviews and Reports, 2024, 20 : 3 - 24
  • [27] Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy
    Borlongan, Mia C.
    Saha, Dipongkor
    Wang, Hongbin
    STEM CELL REVIEWS AND REPORTS, 2024, 20 (01) : 3 - 24
  • [28] Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
    Gadiyar, Varsha
    Lahey, Kevin C.
    Calianese, David
    Devoe, Connor
    Mehta, Dhriti
    Bono, Kristy
    Desind, Samuel
    Davra, Viralkumar
    Birge, Raymond B.
    CELLS, 2020, 9 (10)
  • [29] Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
    Ponomarev, Alexey
    Gilazieva, Zarema
    Solovyeva, Valeriya
    Allegrucci, Cinzia
    Rizvanov, Albert
    CANCERS, 2022, 14 (04)
  • [30] Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
    Sun, Jie
    Zhang, Zicheng
    Bao, Siqi
    Yan, Congcong
    Hou, Ping
    Wu, Nan
    Su, Jianzhong
    Xu, Liangde
    Zhou, Meng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)